Franklin Resources
ENTA icon

Franklin Resources’s Enanta Pharmaceuticals ENTA Stock Holding History

Franklin Resources’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$707K Sell
48,518
-18,429
-28% -$248K ﹤0.01% 2435
2026
Q1 		$846K Buy
66,947
+34,227
+105% +$459K ﹤0.01% 2244
2025
Q4 		$516K Buy
+32,720
New +$416K ﹤0.01% 2388
2024
Q4 		– Sell
-25,593
Closed -$289K – 2950
2024
Q3 		$289K Sell
25,593
-586
-2% -$7.66K ﹤0.01% 2503
2024
Q2 		$340K Sell
26,179
-2,887
-10% -$39K ﹤0.01% 2391
2024
Q1 		$507K Buy
+29,066
New +$385K ﹤0.01% 2238
2023
Q2 		– Sell
-4,994
Closed -$202K – 2735
2023
Q1 		$202K Sell
4,994
-31
-0.6% -$1.48K ﹤0.01% 2000
2022
Q4 		$234K Sell
5,025
-952
-16% -$43.4K ﹤0.01% 1952
2022
Q3 		$309K Buy
+5,977
New +$349K ﹤0.01% 1840
2022
Q1 		– Sell
-2,761
Closed -$206K – 2464
2021
Q4 		$206K Buy
+2,761
New +$217K ﹤0.01% 2231
2018
Q3 		– Sell
-268,025
Closed -$31.1M – 1524
2018
Q2 		$31.1M Sell
268,025
-17,775
-6% -$1.77M 0.02% 658
2018
Q1 		$23.1M Sell
285,800
-31,900
-10% -$2.46M 0.01% 745
2017
Q4 		$18.6M Buy
317,700
+117,700
+59% +$5.89M 0.01% 810
2017
Q3 		$9.36M Buy
+200,000
New +$8.04M ﹤0.01% 961
2014
Q1 		– Sell
-299,000
Closed -$8.16M – 1540
2013
Q4 		$8.16M Sell
299,000
-231,700
-44% -$5.62M ﹤0.01% 1035
2013
Q3 		$12.2M Buy
530,700
+50,800
+11% +$971K 0.01% 929
2013
Q2 		$8.5M Buy
+479,900
New +$9.36M ﹤0.01% 976

Other funds holding ENTA

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KAM
Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Franklin Resources's ENTA Position: Q2 2026 in Review

Franklin Resources reduced its Enanta Pharmaceuticals (ENTA) stake by 28% in Q2 2026, selling an estimated $248K and leaving 48,518 shares worth $707K. The position accounts for ﹤0.01% of the portfolio, ranked #2435.

Franklin Resources first reported a position in ENTA in Q2 2013 and has held it in 17 quarters since. The position peaked at $31.1M in Q2 2018. 123 funds tracked by Wall St. Rank hold ENTA as of Q2 2026.

  • Franklin Resources held 48,518 shares of Enanta Pharmaceuticals worth $707K as of Q2 2026.
  • Franklin Resources sold 18,429 Enanta Pharmaceuticals shares in Q2 2026, an estimated $248K.
  • Enanta Pharmaceuticals made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #2435 holding.
  • Franklin Resources first reported a position in Enanta Pharmaceuticals in Q2 2013 and has held it in 17 quarters since.
  • Franklin Resources's Enanta Pharmaceuticals position peaked at $31.1M in Q2 2018.
  • 123 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.